Acquired Coagulopathy and Hemorrhage Secondary to Subcutaneous Heparin Prophylaxis

Figure 1

(a) Timeline of heparin clearance with protamine administration. Left y-axis: aPTT; right y-axis: anti-Xa. Arrows demarcate timing and dose of protamine administration. aPTT: activated partial thromboplastin time; reference range 27–38 seconds. Anti-Xa: antifactor Xa activity; reference 0 or <0.3 IU/mL for prophylactic dosing; reference range 0.3–0.7 for therapeutic anticoagulation. (b) Clinical timeline. Activated partial thromboplastin time and thrombin time measured in seconds. Anti-Xa measured in IU/mL. (c) Representative axial images from the patient’s chest CT demonstrating multifocal soft tissue hematomas (arrows).

(a)

(b)

(c)